We are thrilled to announce the successful conclusion of our exhibition at the Medica 2024 in Germany. The event, which took place over several days, provided a platform for Tongzhou Biotech to not only showcase our established, popular products but also to introduce a range of innovative new diagnostic solutions to the market.

We presented the latest additions to our product line, including the HPV Rapid Test, Adenovirus/RSV/HMPV/HPIV/Influenza A+B Combo Rapid Test, Celiac Rapid Test, and the Canine/Feline Allergen IgE Immunoblot Test. These products were met with overwhelming enthusiasm and praise from our partners and IVD industry professionals. The positive feedback and recognition from the industry reinforce our commitment to developing cutting-edge diagnostic tools that contribute to the advancement of human health. We are grateful for the support and trust placed in Tongzhou Biotech by our partners and the wider medical community.

As we reflect on the success of Medica 2024, we are already looking forward to the future. Tongzhou Biotech remains dedicated to building upon our achievements and to continuing our mission to enhance healthcare globally. We are excited to announce that we will be participating in medlab 2025, set to take place in February in Dubai. We invite our partners and professionals in the IVD sector to join us as we continue to innovate and grow!